Characterization of microvesicles in B-Cell chronic lymphocytic leukemia (CLL): A potential mediator in CLL B cell disease progression?

被引：0
|
作者：
Ghosh, Asish K. [1 ]
Kay, Neil E. [1 ]
机构：
[1] Mayo Clin, Div Hematol, Rochester, MN USA
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.747.747
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
747
引用
收藏
页码：230A / 230A
页数：1
相关论文
共 50 条
  • [41] Prognostic relevance of CD38 expression in B-cell chronic lymphocytic leukemia (B-CLL)
    D'Arena, G.
    Napolitano, M.
    Marcacci, G.
    Russo, F.
    Vigliotti, M. L.
    Mauro, F.
    Corazzelli, G.
    Frigeri, F.
    Della Cioppa, P.
    Svanera, G.
    Capobianco, G.
    Nasuti, A.
    Villani, O.
    Pinto, A.
    CYTOMETRY PART A, 2006, 69A (05) : 449 - 449
  • [42] A CASE OF CLASSICAL KAPOSIS-SARCOMA IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL)
    CONTU, L
    CARCASSI, C
    LANASA, G
    ZURRIDA, SM
    SIRIGU, F
    DELGIACCO, S
    CERIMELE, D
    LONGINOTTI, M
    PITZUS, F
    TUMORI, 1986, 72 (04) : 365 - 374
  • [43] Clinical significance of CD69 expression in B-cell Chronic Lymphocytic Leukemia (B-CLL)
    Del Poeta, G.
    Del Principe, M., I
    Luciano, F.
    Maurillo, L.
    Buccisano, F.
    Gattei, V
    Niscola, P.
    Venditti, A.
    Imo Consalvo, M.
    Catalano, G.
    de Fabritiis, P.
    Amadori, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 108 - 108
  • [44] Cladribine in combination with mitoxantrone and cyclophosphamide (CMC) in the treatment of B-cell chronic lymphocytic leukemia (B-CLL).
    Robak, T
    Blonski, JZ
    Kasznicki, M
    Gora-Tybor, J
    Konopka, L
    Dmoszynska, A
    Skotnicki, AB
    Stella-Holowiecka, B
    Kuliczkowski, K
    Dwilewicz-Trojaczek, J
    BLOOD, 2000, 96 (11) : 293B - 293B
  • [45] Consolidation with rituximab improves outcome in high risk B-cell chronic lymphocytic leukemia (B-CLL)
    Del, Poeta G.
    Del, Principe M., I
    Maurillo, L.
    Buccisano, F.
    Niscola, F.
    Catalano, G.
    Venditti, A.
    Gattei, V
    Perrotti, A. P.
    de Fabritiis, F.
    Amadori, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 23 - 23
  • [46] Second malignancies in B-cell chronic lymphocytic leukemia (CLL): Association with CLL but no additional impact with fludarabine or alkylator treatment.
    Flynn, JM
    Howard, RS
    Byrd, JC
    BLOOD, 1999, 94 (10) : 298B - 298B
  • [47] Reconstitution of the T cell repertoire following treatment with alemtuzumab in patients with B-cell chronic lymphocytic leukemia (B-CLL).
    Rezvany, MR
    Tehrani, MJ
    Karlsson, C
    Lundin, J
    Rabbani, H
    Mellstedt, K
    Österborg, A
    BLOOD, 2005, 106 (11) : 837A - 837A
  • [48] Allogeneic stem cell transplantation from related or unrelated donors for B-cell chronic lymphocytic leukemia (B-CLL).
    Pavletic, ZS
    Arrowsmith, ER
    Bierman, PJ
    Goodman, SA
    Vose, JM
    Tarantolo, SR
    Stein, RS
    Greer, JP
    Kollath, JP
    Weisenburger, DD
    Wolff, SN
    Armitage, JO
    Bishop, MR
    BLOOD, 1998, 92 (10) : 288A - 288A
  • [49] Feasibility of autologous stem cell transplantation in patients (pts) with advanced B-cell chronic lymphocytic leukemia (CLL).
    Sutton, L
    Maloum, K
    Boccaccio, C
    Albin, N
    Manighetti, J
    Cosset, JM
    Binet, JL
    Leblond, V
    BLOOD, 1996, 88 (10) : 3614 - 3614
  • [50] Frequency of 5′ IGH deletions in B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
    Nooraie, F.
    Quintero-Rivera, F.
    Rao, P. N.
    CYTOGENETIC AND GENOME RESEARCH, 2008, 121 (01)
12345